TY - JOUR
T1 - Appropriate use of complementary and alternative medicine approaches in gynecologic cancers
AU - Chase, Dana M.
AU - Gibson, Steven J.
AU - Sumner, Daniele A.
AU - Bea, Jennifer W.
AU - Alberts, David S.
PY - 2014/3
Y1 - 2014/3
N2 - Gynecologic cancer patients frequently desire alternative and/or complementary interventions or medicines to aid in relief of both cancer-related and treatment-related side effects. Furthermore, women also seek treatment to aid in superior outcomes and cure rates. Unfortunately, evidence suggests that the use of complementary and/or alternative medicine (CAM) is underreported or not discussed with physicians providing cancer care. In gynecologic cancer literature, there is a lack of scientific evidence either supporting or negating CAM. Because of the lack of information available, health care providers do not have good information regarding safety, efficacy, and dose of CAM. This leads to miscommunication or absence of communication between providers and patients. Because patients do use CAM to improve quality of life (QOL) during and after treatment, it would be educational for providers to know the specific QOL deficits among patients that require attention. Thus, with the ultimate goal of improving QOL for gynecologic cancer patients, providers should be pushed to investigate CAM and determine an honest support or rejection of these therapies.
AB - Gynecologic cancer patients frequently desire alternative and/or complementary interventions or medicines to aid in relief of both cancer-related and treatment-related side effects. Furthermore, women also seek treatment to aid in superior outcomes and cure rates. Unfortunately, evidence suggests that the use of complementary and/or alternative medicine (CAM) is underreported or not discussed with physicians providing cancer care. In gynecologic cancer literature, there is a lack of scientific evidence either supporting or negating CAM. Because of the lack of information available, health care providers do not have good information regarding safety, efficacy, and dose of CAM. This leads to miscommunication or absence of communication between providers and patients. Because patients do use CAM to improve quality of life (QOL) during and after treatment, it would be educational for providers to know the specific QOL deficits among patients that require attention. Thus, with the ultimate goal of improving QOL for gynecologic cancer patients, providers should be pushed to investigate CAM and determine an honest support or rejection of these therapies.
KW - Alternative medicine
KW - Cervical cancer
KW - Complementary medicine
KW - Gynecologic cancer
KW - Ovarian cancer
UR - https://www.scopus.com/pages/publications/84894663649
UR - https://www.scopus.com/inward/citedby.url?scp=84894663649&partnerID=8YFLogxK
U2 - 10.1007/s11864-013-0269-x
DO - 10.1007/s11864-013-0269-x
M3 - Article
C2 - 24398574
AN - SCOPUS:84894663649
SN - 1527-2729
VL - 15
SP - 14
EP - 26
JO - Current Treatment Options in Oncology
JF - Current Treatment Options in Oncology
IS - 1
ER -